Regulatory Strategies for API going off-patent
Pharmaceutical industries are one of the most developing industries having enormous profit margins. Today the pharmaceutical companies are challenged with increased costs of drug discovery and development and intrusive competition from generic drug companies. The pharmaceutical companies have begun the process of drug development and in the same period also begin to espouse the various schemes to expand the duration of patent-holding. So, increasing patent term for the already patented products is an effective strategy for withstanding generic competition. Pharmaceutical industries can use various ways to optimize the patent protection on large products, optimizing the market lifecycles and the strategies for API going off-patent in pharmaceutical industries in India are outlined below to provide the significant pharmaceutical patenting information.
2. Mathur V."Patenting of pharmaceuticals. An Indian perspective", Int. J. Drug. Dev. and Res [Internet].2012 Jul-Sept [cited in 2020 Jan 02]; 4(3)27-34. Available from:
3. Ducray. P. Compounds of formula I and a process for their preparation. Indian patent IN 202989; 2006.
4. Mukherjee S. The new Indian patent law: a challenge for India. Int. J. Prop Manage. 2006; 1(1/2):131-49.
5. FDA/CDER/SBIA Chronicles [Internet]. 2015 May 19 [cited in 2020 Jan 03]. Available from:
6. Drugs coming off-patent by 2022.International Journal of Pharmaceutical Sciences Review and Research [Internet]. [cited in 2020 Jan 04]. Available from:
7. Gupta H, Kumar S, R S.K, and Gaud R.S. Patent protection strategies. J Pharm Bioallied Sci. [Internet]. 2010 Jan -Mar [cited in 2020 Jan 06]; 2(1):2-7. Available from:
8. Pharmagenerics: Emerging from the shadows of brand power [Internet]. [cited in 2020 Jan 03]. Available from:
9. Kinjal Suchak, Lisa J. Murray." Patent Centric Strategies for Drug Re-innovation", Journal of Pharmaceutical Innovation [Internet].2018. [cited in 2020 Jan 04]. Available from:
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM